Douglas R. Cary

1.2k total citations
24 papers, 787 citations indexed

About

Douglas R. Cary is a scholar working on Organic Chemistry, Molecular Biology and Inorganic Chemistry. According to data from OpenAlex, Douglas R. Cary has authored 24 papers receiving a total of 787 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Organic Chemistry, 10 papers in Molecular Biology and 7 papers in Inorganic Chemistry. Recurrent topics in Douglas R. Cary's work include Click Chemistry and Applications (4 papers), Chemical Synthesis and Analysis (3 papers) and Synthesis and characterization of novel inorganic/organometallic compounds (3 papers). Douglas R. Cary is often cited by papers focused on Click Chemistry and Applications (4 papers), Chemical Synthesis and Analysis (3 papers) and Synthesis and characterization of novel inorganic/organometallic compounds (3 papers). Douglas R. Cary collaborates with scholars based in Japan, United Kingdom and Canada. Douglas R. Cary's co-authors include John Arnold, Dermot O’Hare, Shin‐Guang Shyu, Andrew M. Fogg, Graham E. Ball, Hidehisa Iwata, Hiroshi Miki, Jennifer C. Green, Satoshi Sogabe and S. Igaki and has published in prestigious journals such as Journal of the American Chemical Society, Chemistry of Materials and Chemical Communications.

In The Last Decade

Douglas R. Cary

24 papers receiving 746 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Douglas R. Cary Japan 15 344 236 235 208 137 24 787
Éric Benoist France 18 375 1.1× 211 0.9× 177 0.8× 118 0.6× 299 2.2× 71 838
Maria Paula Cabral Campello Portugal 20 200 0.6× 358 1.5× 404 1.7× 181 0.9× 240 1.8× 61 1.1k
Luı́s M. P. Lima Portugal 21 231 0.7× 579 2.5× 178 0.8× 335 1.6× 443 3.2× 43 1.2k
Chuanmin Qi China 15 230 0.7× 164 0.7× 188 0.8× 87 0.4× 123 0.9× 44 658
John D. Lydon United States 10 261 0.8× 169 0.7× 97 0.4× 205 1.0× 429 3.1× 16 845
Hitoshi Iikura Japan 13 565 1.6× 430 1.8× 184 0.8× 98 0.5× 98 0.7× 18 836
Menyhárt B. Sárosi Germany 18 480 1.4× 254 1.1× 132 0.6× 272 1.3× 177 1.3× 64 1.1k
Cara L. Ferreira Canada 19 161 0.5× 234 1.0× 133 0.6× 139 0.7× 327 2.4× 30 1.1k
N. Cutillas Spain 22 1.0k 3.0× 280 1.2× 223 0.9× 263 1.3× 880 6.4× 41 1.5k
Patricia A. Marzilli United States 21 432 1.3× 292 1.2× 360 1.5× 255 1.2× 550 4.0× 60 1.1k

Countries citing papers authored by Douglas R. Cary

Since Specialization
Citations

This map shows the geographic impact of Douglas R. Cary's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas R. Cary with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas R. Cary more than expected).

Fields of papers citing papers by Douglas R. Cary

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas R. Cary. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas R. Cary. The network helps show where Douglas R. Cary may publish in the future.

Co-authorship network of co-authors of Douglas R. Cary

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas R. Cary. A scholar is included among the top collaborators of Douglas R. Cary based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas R. Cary. Douglas R. Cary is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hayashi, Kyohei, Shota Uehara, Shiho Yamamoto, et al.. (2021). Macrocyclic Peptides as a Novel Class of NNMT Inhibitors: A SAR Study Aimed at Inhibitory Activity in the Cell. ACS Medicinal Chemistry Letters. 12(7). 1093–1101. 15 indexed citations
3.
Kobayashi, Yutaka, et al.. (2020). Isostearyl Mixed Anhydrides for the Preparation ofN-Methylated Peptides UsingC-Terminally UnprotectedN-Methylamino Acids. Organic Letters. 22(20). 8039–8043. 13 indexed citations
4.
Nogami, Masahiro, Misa Iwatani, Toshihiro Imaeda, et al.. (2020). Identification of a selective DDX3X inhibitor with newly developed quantitative high-throughput RNA helicase assays. Biochemical and Biophysical Research Communications. 523(3). 795–801. 10 indexed citations
5.
Ito, Masahiro, Toshio Tanaka, Douglas R. Cary, et al.. (2017). Discovery of Novel 1,4-Diacylpiperazines as Selective and Cell-Active eIF4A3 Inhibitors. Journal of Medicinal Chemistry. 60(8). 3335–3351. 28 indexed citations
6.
Cary, Douglas R., et al.. (2017). Constrained Peptides in Drug Discovery and Development. Journal of Synthetic Organic Chemistry Japan. 75(11). 1171–1178. 34 indexed citations
7.
Fujimoto, Jun, Takaharu Hirayama, Yasuhiro Hirata, et al.. (2017). Studies of CDK 8/19 inhibitors: Discovery of novel and selective CDK8/19 dual inhibitors and elimination of their CYP3A4 time-dependent inhibition potential. Bioorganic & Medicinal Chemistry. 25(12). 3018–3033. 16 indexed citations
8.
Ono, Koji, Hiroshi Banno, Masanori Okaniwa, et al.. (2017). Design and synthesis of selective CDK8/19 dual inhibitors: Discovery of 4,5-dihydrothieno[3′,4′:3,4]benzo[1,2-d]isothiazole derivatives. Bioorganic & Medicinal Chemistry. 25(8). 2336–2350. 27 indexed citations
9.
Oguro, Yuya, Douglas R. Cary, Naoki Miyamoto, et al.. (2013). Design, synthesis, and evaluation of novel VEGFR2 kinase inhibitors: Discovery of [1,2,4]triazolo[1,5-a]pyridine derivatives with slow dissociation kinetics. Bioorganic & Medicinal Chemistry. 21(15). 4714–4729. 38 indexed citations
10.
Sogabe, Satoshi, Youichi Kawakita, S. Igaki, et al.. (2012). Structure-Based Approach for the Discovery of Pyrrolo[3,2-d]pyrimidine-Based EGFR T790M/L858R Mutant Inhibitors. ACS Medicinal Chemistry Letters. 4(2). 201–205. 136 indexed citations
11.
Cary, Douglas R., Kelsey M. Gray, Stephen M. Lane, et al.. (2002). Rhenium Bipyridine Complexes for the Recognition of Glucose. Inorganic Chemistry. 41(6). 1662–1669. 27 indexed citations
12.
Cary, Douglas R., Stephen M. Lane, Thomas A. Peyser, et al.. (2002). Ruthenium bipyridine complexes for the recognition of glucose. Sensors and Actuators B Chemical. 87(1). 25–32. 6 indexed citations
13.
Roussel, P., Douglas R. Cary, Stephen Barlow, et al.. (2000). Ligand-Centered Oxidation in a Diiron s-Indacene Complex. Organometallics. 19(6). 1071–1076. 17 indexed citations
14.
Fogg, Andrew M., et al.. (1998). Selective Ion-Exchange Intercalation of Isomeric Dicarboxylate Anions into the Layered Double Hydroxide [LiAl2(OH)6]Cl·H2O. Chemistry of Materials. 10(1). 351–355. 157 indexed citations
15.
Roussel, P., et al.. (1998). Unusual reactivity and isomerisation in dicobalt s-indacene complexes. Chemical Communications. 2205–2206. 14 indexed citations
16.
Cary, Douglas R., et al.. (1997). New strongly coupled dinuclear metal centres in organometallic s-indacene complexes. Chemical Communications. 953–954. 21 indexed citations
17.
Barlow, Stephen, Douglas R. Cary, Mark J. Drewitt, & Dermot O’Hare. (1997). Synthesis and structures of organometallic derivatives of 1,2,3,4,5,6,7,8-octamethyl-1,5-dihydro-s-indacene. Journal of the Chemical Society Dalton Transactions. 3867–3878. 8 indexed citations
18.
Cary, Douglas R., Jennifer C. Green, & Dermot O’Hare. (1997). Synthetic, Structural, and Bonding Studies of Indacene Dianions. Angewandte Chemie International Edition in English. 36(23). 2618–2620. 20 indexed citations
19.
Cary, Douglas R., Graham E. Ball, & John Arnold. (1995). Trivalent Lanthanide Selenolates and Tellurolates Incorporating Sterically Hindered Ligands and Their Characterization by Multinuclear NMR Spectroscopy and X-ray Crystallography. Journal of the American Chemical Society. 117(12). 3492–3501. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026